摘要
目的观察水蛭通络散剂治疗缺血性中风急性期的临床效果。方法选择2015年1月至2017年9月在西安中医脑病医院接受住院治疗的急性期缺血性中风患者84例,根据治疗方法不同将其分为对照组与治疗组,每组42例。对照组给予常规西医治疗,治疗组在对照组基础上给予水蛭通络散剂。比较两组临床疗效、治疗前、治疗后3个月的NIHSS、BI评分和药物不良反应发生情况。结果治疗组患者的临床治疗总有效率显著高于对照组(P<0.05)。治疗后3个月,两组患者的NIHSS评分均降低,BI评分均升高,且治疗组均优于对照组(P<0.05)。两组患者的不良反应总发生率比较,差异无统计学意义(P>0.05)。结论水蛭通络散剂治疗急性期缺血性中风的临床效果显著,有助于患者神经功能的恢复与日常生活能力的提高,且不存在严重不良反应,值得临床借鉴。
Objective To observe the clinical effect of Shuizhi Tongluo powder on acute ischemic apoplexy. Methods From January 2015 to September 2017, 84 patients with acute ischemic apoplexy hospitalized and treated in Xi’an encephalopathy hospital of traditional Chinese medicine were selected and divided into control group and treatment group according to different treatment methods, with 42 cases in each group. The control group was given conventional western medicine treatment, the treatment group was given Shuizhi Tongluo powder on the basis of the control group. The clinical efficacy, NIHSS, BI scores before and at 3 months after treatment and adverse drug reactions of the two groups were compared. Results The total effective rate of clinical treatment in the treatment group was significantly higher than that in the control group(P<0.05). At three months after treatment, the NIHSS scores of the two groups decreased, the BI scores increased, and those of the treatment group were better than the control group(P<0.05). There was no significant difference in the total incidences of adverse reactions between the two groups(P>0.05). Conclusion The Shuizhi Tongluo powder has a significant clinical effect in the treatment of acute ischemic apoplexy, it is helpful for the recovery of nerve function and the improvement of daily living ability of patients, without serious adverse reaction, which is worth of clinical reference.
作者
李辉
徐晓丹
付成保
杜晓刚
LI Hui;XU Xiao-dan;FU Cheng-bao;DU Xiao-gang(No.5 Encephalopathy Department,Xi'an Encephalopathy Hospital of Traditional Chinese Medicine,Xi'an 710032,China)
出处
《临床医学研究与实践》
2019年第36期149-151,共3页
Clinical Research and Practice
